SCHEMBL5227062

SCHEMBL5227062

NC(=O)OC1CCN(C2CCN(c3ccc(C#Cc4ccc(-c5ccc(Cl)cc5)cn4)cc3)C2)CC1

nearest known ligand 0.51

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 16/20 0.51
CHRM1 P11229 4/20 0.44
HTR2A P28223 3/20 0.44
CYP2D6 P10635 1/20 0.43
HRH3 Q9Y5N1 2/20 0.37
ACACB O00763 1/20 0.35
NOTUM Q6P988 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5232422 0.90 MCHR1 (0.47) MCHR1CHRM1HTR2ACYP2D6HRH3
SCHEMBL6365384 0.89 MCHR1 (0.62) MCHR1CHRM1HTR2ACYP2D6ACACB
SCHEMBL5225115 0.87 MCHR1 (0.49) MCHR1CHRM1HTR2ACYP2D6
SCHEMBL5225175 0.84 MCHR1 (0.59) MCHR1CHRM1HTR2ACYP2D6
SCHEMBL2324871 0.84 MCHR1 (0.53) MCHR1CHRM1HTR2ACYP2D6HRH3
SCHEMBL13933782 0.84 MCHR1 (0.53) MCHR1CHRM1HTR2ACYP2D6HRH3
SCHEMBL5223731 0.83 MCHR1 (0.51) MCHR1CHRM1HTR2ACYP2D6ACACB
SCHEMBL5223297 0.81 MCHR1 (0.47) MCHR1CHRM1HTR2ACYP2D6ACACB
SCHEMBL6365403 0.79 MCHR1 (0.57) MCHR1CHRM1HTR2ACYP2D6HRH3
SCHEMBL5226479 0.79 MCHR1 (0.57) MCHR1CHRM1HTR2ACYP2D6HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1737824-A2 NOVEL ALKYNE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, AND MEDICAMENTS CONTAINING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-01-03 EP disclosed
WO-2005103032-A2 NOVEL ALKYNE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, AND MEDICAMENTS CONTAINING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO disclosed